ATE548050T1 - Diagnoseverfahren - Google Patents

Diagnoseverfahren

Info

Publication number
ATE548050T1
ATE548050T1 AT08759218T AT08759218T ATE548050T1 AT E548050 T1 ATE548050 T1 AT E548050T1 AT 08759218 T AT08759218 T AT 08759218T AT 08759218 T AT08759218 T AT 08759218T AT E548050 T1 ATE548050 T1 AT E548050T1
Authority
AT
Austria
Prior art keywords
hbp
diagnostic procedure
individual
level
ratio
Prior art date
Application number
AT08759218T
Other languages
English (en)
Inventor
Lars Bjorck
Bertil Christensson
Heiko Herwald
Adam Linder
Per Akesson
Original Assignee
Hansa Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38331957&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE548050(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hansa Medical Ab filed Critical Hansa Medical Ab
Application granted granted Critical
Publication of ATE548050T1 publication Critical patent/ATE548050T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis
AT08759218T 2007-06-12 2008-06-12 Diagnoseverfahren ATE548050T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0711327.7A GB0711327D0 (en) 2007-06-12 2007-06-12 Diagnostic method
PCT/EP2008/004743 WO2008151808A1 (en) 2007-06-12 2008-06-12 Diagnostic method

Publications (1)

Publication Number Publication Date
ATE548050T1 true ATE548050T1 (de) 2012-03-15

Family

ID=38331957

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08759218T ATE548050T1 (de) 2007-06-12 2008-06-12 Diagnoseverfahren

Country Status (16)

Country Link
US (3) US8518648B2 (de)
EP (1) EP2129391B1 (de)
JP (1) JP5166522B2 (de)
KR (1) KR101563997B1 (de)
CN (2) CN101687023B (de)
AT (1) ATE548050T1 (de)
AU (1) AU2008261252B2 (de)
BR (1) BRPI0812875B8 (de)
CA (1) CA2690067C (de)
DK (1) DK2129391T3 (de)
ES (1) ES2380875T3 (de)
GB (1) GB0711327D0 (de)
PL (1) PL2129391T3 (de)
PT (1) PT2129391E (de)
SI (1) SI2129391T1 (de)
WO (1) WO2008151808A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0711327D0 (en) 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
US20100240049A1 (en) 2009-01-16 2010-09-23 Cepheid Methods of Detecting Cervical Cancer
JP5488885B2 (ja) * 2009-10-28 2014-05-14 国立大学法人 東京大学 感染症の疾患マーカー
GB201016161D0 (en) * 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
EP2643483A4 (de) * 2010-11-26 2014-04-30 Immunexpress Pty Ltd Diagnose- und/oder screening-mittel und verwendungen dafür
GB201102108D0 (en) * 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method
EP2756118A4 (de) * 2011-09-16 2015-09-16 Cepheid Verfahren für den nachweis von sepsis
US10260111B1 (en) 2014-01-20 2019-04-16 Brett Eric Etchebarne Method of detecting sepsis-related microorganisms and detecting antibiotic-resistant sepsis-related microorganisms in a fluid sample
WO2016057945A1 (en) 2014-10-09 2016-04-14 Texas Tech University System Micro-device to detect infection
CN109541235A (zh) * 2018-08-19 2019-03-29 重庆早柒天生物科技股份有限公司 肝素结合蛋白和降钙素原二联检测试剂盒及其制备方法
EP3960758A4 (de) 2019-04-24 2023-02-15 Japanese Foundation For Cancer Research Verfahren zum nachweis von krebs und nachweisreagenz
CN111208305B (zh) * 2020-02-16 2023-04-25 重庆翼锋生物科技有限公司 Hbp和pct在败血症诊断试剂制备中的用途
CN111951963B (zh) 2020-07-30 2022-09-02 中翰盛泰生物技术股份有限公司 Hbp在covid-19患者的预后风险预警中的应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627262A (en) * 1989-07-05 1997-05-06 The Board Of Regents Of The University Of Oklahoma Method and composition for the treatment of septic shock
US5962241A (en) * 1989-07-28 1999-10-05 The University Of Arizona Monoclonal antibody detection of proteins on sperm related to fertility
US5314804A (en) * 1992-03-24 1994-05-24 Serim Research Corporation Test for Helicobacter pylori
DE69530689T2 (de) 1994-04-21 2004-03-25 Leukotech A/S Heparin-binding protein zur behandlung von sepsis
US5976536A (en) 1995-08-09 1999-11-02 Emory University Neisseria mutants, lipooligosaccharides and immunogenic compositions
US5778895A (en) 1997-01-29 1998-07-14 Uab Research Foundation Method of discriminating bacterial from aseptic meningitis
US6303321B1 (en) 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US20030170745A1 (en) 2002-03-08 2003-09-11 Pereira Heloise Anne Early detection marker for chronic inflammatory associated diseases
US7655480B2 (en) * 2002-03-08 2010-02-02 The Board Of Regents Of The University Of Oklahoma Method for predicting sepsis or an acute infectious inflammatory response
US20060173162A1 (en) 2002-08-15 2006-08-03 Rene Djurup Bactericidak anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp)
US20040167320A1 (en) * 2003-02-24 2004-08-26 Couto Daniel E. Methods of tangential flow filtration and an apparatus therefore
US7191068B2 (en) * 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
CA2529503A1 (en) 2003-06-20 2004-12-29 Royer Biomedical, Inc. Drug polymer complexes
US20070269437A1 (en) 2003-09-19 2007-11-22 Leukotech A/S Pro-Inflammatory and Anti-Inflammatory Antibodies Against the Heparin-Binding Protein (Hbp)
US20050196817A1 (en) * 2004-01-20 2005-09-08 Molecular Staging Inc. Biomarkers for sepsis
KR20080006617A (ko) * 2005-04-15 2008-01-16 백톤 디킨슨 앤드 컴퍼니 패혈증의 진단
EP1931990A4 (de) * 2005-10-03 2010-03-10 Biosite Inc Verfahren und zusammensetzungen zur diagnose und/oder prognose bei systemischen inflammatorischen response-syndromen
FR2894675B1 (fr) 2005-12-14 2008-06-27 Assist Publ Hopitaux De Paris Distinction des meningites bacteriennes et virales
GB0711327D0 (en) 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
GB201016161D0 (en) 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
GB201102108D0 (en) 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method

Also Published As

Publication number Publication date
AU2008261252A1 (en) 2008-12-18
KR20100021578A (ko) 2010-02-25
GB0711327D0 (en) 2007-07-25
JP5166522B2 (ja) 2013-03-21
EP2129391B1 (de) 2012-03-07
US20100305185A1 (en) 2010-12-02
WO2008151808A1 (en) 2008-12-18
EP2129391A1 (de) 2009-12-09
CA2690067C (en) 2023-09-19
CA2690067A1 (en) 2008-12-18
AU2008261252B2 (en) 2013-03-14
CN103543271A (zh) 2014-01-29
US9784741B2 (en) 2017-10-10
US20140187503A1 (en) 2014-07-03
BRPI0812875B8 (pt) 2022-07-12
JP2010529468A (ja) 2010-08-26
DK2129391T3 (da) 2012-06-11
PL2129391T3 (pl) 2012-09-28
SI2129391T1 (sl) 2012-07-31
CN101687023A (zh) 2010-03-31
US20130252347A1 (en) 2013-09-26
ES2380875T3 (es) 2012-05-21
PT2129391E (pt) 2012-06-06
US8518648B2 (en) 2013-08-27
BRPI0812875B1 (pt) 2017-12-05
BRPI0812875A2 (pt) 2014-12-09
KR101563997B1 (ko) 2015-10-28
CN101687023B (zh) 2016-04-20

Similar Documents

Publication Publication Date Title
DK2129391T3 (da) Diagnostisk fremgangsmåde
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
CY1120434T1 (el) Πρωτεϊνες προσδεσης il-1
EA200971131A1 (ru) Биомаркеры для прогнозирования чувствительности или отсутствия чувствительности к анти-фно агентам
CO6410314A2 (es) Proteínas de unión a il-17
EA201201199A1 (ru) Антагонисты активин-actrii и их применения для повышения уровней эритроцитов
UY34736A (es) ?compuestos de indol e indazol que activan la ampk?.
MA30497B1 (fr) Anticorps et immunco-conjugues, et leurs utilisations.
CO6450665A2 (es) Anticuerpos anti-fgfr3 y métodos que los utilizan
CL2010001483A1 (es) Compuestos derivados de 5-fenil-1h-piridin-2-ona y 6-fenil-2h-piridazin-3-ona, inhibidores de tirosina-quinasa (btk); composicion farmaceutica que comprende a dichos compuestos y su uso para el tratamiento de un estado patologico inflamatorio y/o autoinmune.
EA201270553A1 (ru) Ингибиторы тирозинкиназы брутона
EA200701918A1 (ru) Белок липокалин
GT200600112A (es) Composiciiones de tigeciclina y metodos de preparacion
MA34521B1 (fr) Polypeptides de relaxine modifiés et leurs utilisations
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
WO2015070001A3 (en) Compositions and methods for detecting and/or treating inflammation
NO20084320L (no) Antistoffer mot EGFL7 og fremgangsmater for anvendelse av disse
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
ATE549638T1 (de) 13c-mr-bildgebung oder spektroskopie von zelltod
GB201102108D0 (en) Diagnostic method
BR112017000490A2 (pt) componente condutor de fluxo
ATE483720T1 (de) Verbindungen enthaltend organofluorochlorophosphatanionen
HK1112928A1 (en) Cspcna isoform modifications and uses thereof
PL390933A1 (pl) Rozpraszacz dyfuzyjny do nasycania wody gazem, zestaw do nasycania wody gazem, sposób nasycania wody gazem i zastosowanie
EA201171196A1 (ru) Системы и способы определения оптимального количества и положения платформ